Congress Looks At Expanding Doctors’ Residencies
The goal is to reduce doctor shortages, especially primary care physicians. “We don’t necessarily need more dermatologists on Park Avenue in New York City,” Sen. Bernie Sanders said. Other health care worker shortages are feared.
Roll Call:
Sanders Says US Physician Shortage Is A ‘Solvable Problem’
Senators on both sides of the aisle agreed at a hearing Thursday that Congress should work to address the nation’s physician shortages, especially in primary health care, including through changes to training programs. At a Health, Education, Labor and Pensions Primary Health and Retirement Security Subcommittee hearing, Chair Bernie Sanders said the federal government could help boost the number of practicing physicians in the United States. The government spends about $16 billion every year to fund thousands of medical residency programs. (Cohen, 5/20)
ABC News:
Pandemic Has Made Shortage Of Health Care Workers Even Worse, Say Experts
The COVID-19 pandemic has exacerbated the ongoing shortage of health workers, leaving many health care facilities short-staffed even as the number of nationwide coronavirus cases plummets, experts say. "Nurse shortages are a long-standing issue, but because of COVID, it is anticipated to grow even more by next year," Dr. Ernest Grant, president of the American Nurses Association, told ABC News. "Nurses and other health workers are overworked and they are exhausted from the pandemic." (Romero and Bhatt, 5/21)
In other news from Capitol Hill —
AP:
As Pandemic Spread Pain And Panic, Congressman Chased Profit
In the early days of the pandemic, New Jersey Rep. Tom Malinowski scolded those looking to capitalize on the once-in-a-century health crisis. ... He did not heed his own admonition. Since early 2020, Malinowski has bought or sold as much as $1 million of stock in medical and tech companies that had a stake in the virus response, according to an analysis of records by The Associated Press. The trades were just one slice of a stock buying and selling spree by the congressman in 2020, worth as much as $3.2 million, that he did not properly disclose. (Slodysko, 5/21)
Axios:
Prescription Drug Price Fight Gets A Funding Infusion
Millions of dollars are being poured into the fight over prescription drug costs — and not just from pharmaceutical companies and their allies. Consumer groups are making clear that they're not letting up on the issue, either. Lowering prescription drug costs has been a top Democratic priority for years and is hugely popular among the public, a fact that both supporters and opponents of reform aren't taking lightly. (Owens, 5/21)
